ECSP099537A - METHODS FOR IMPROVED STABILITY OF STEROID DERIVATIVES - Google Patents

METHODS FOR IMPROVED STABILITY OF STEROID DERIVATIVES

Info

Publication number
ECSP099537A
ECSP099537A EC2009009537A ECSP099537A ECSP099537A EC SP099537 A ECSP099537 A EC SP099537A EC 2009009537 A EC2009009537 A EC 2009009537A EC SP099537 A ECSP099537 A EC SP099537A EC SP099537 A ECSP099537 A EC SP099537A
Authority
EC
Ecuador
Prior art keywords
improved stability
methods
steroid derivatives
steroid
derivatives
Prior art date
Application number
EC2009009537A
Other languages
Spanish (es)
Inventor
Joseph Podolski
Original Assignee
Repros Therapeutis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutis Inc filed Critical Repros Therapeutis Inc
Publication of ECSP099537A publication Critical patent/ECSP099537A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proveen composiciones con estabilidad mejorada que comprenden una sal farmacéuticamente aceptable de un compuesto relacionado con esteroides.Compositions with improved stability are provided comprising a pharmaceutically acceptable salt of a steroid related compound.

EC2009009537A 2007-01-17 2009-07-23 METHODS FOR IMPROVED STABILITY OF STEROID DERIVATIVES ECSP099537A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88536307P 2007-01-17 2007-01-17

Publications (1)

Publication Number Publication Date
ECSP099537A true ECSP099537A (en) 2009-08-28

Family

ID=39387140

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009537A ECSP099537A (en) 2007-01-17 2009-07-23 METHODS FOR IMPROVED STABILITY OF STEROID DERIVATIVES

Country Status (16)

Country Link
EP (1) EP2125858A2 (en)
JP (1) JP2010516686A (en)
KR (1) KR20090105944A (en)
CN (1) CN101616926A (en)
AR (1) AR064947A1 (en)
AU (1) AU2008206599A1 (en)
BR (1) BRPI0806572A2 (en)
CA (1) CA2674440A1 (en)
CL (1) CL2008000138A1 (en)
CR (1) CR10924A (en)
EA (1) EA200970692A1 (en)
EC (1) ECSP099537A (en)
IL (1) IL199684A0 (en)
MX (1) MX2009007313A (en)
TW (1) TW200835503A (en)
WO (1) WO2008088935A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI477276B (en) * 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
HUP0900171A2 (en) * 2009-03-20 2010-12-28 Richter Gedeon Nyrt Novel crystal form of 17-acetoxy-11›-[4-(dimethyl-amino)-phenyl]-21-metoxy-19-norpregna-4,9-dien-3,20-dione and process for it's preparation
HUP0900487A2 (en) * 2009-08-05 2011-03-28 Richter Gedeon Nyrt Novel crystal polymorphic form of 17-acetoxy-11 -[4-(dimethylamino)phenyl]-21-methoxy-4,9-diene-3,20-dione and process for it's preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US8044223B2 (en) * 2003-04-04 2011-10-25 Bridge Organics Co. Crystalline 19-norsteroids

Also Published As

Publication number Publication date
BRPI0806572A2 (en) 2014-05-06
IL199684A0 (en) 2010-04-15
CA2674440A1 (en) 2008-07-24
CR10924A (en) 2009-10-30
WO2008088935A3 (en) 2009-03-05
EA200970692A1 (en) 2010-02-26
EP2125858A2 (en) 2009-12-02
CL2008000138A1 (en) 2008-05-16
AU2008206599A1 (en) 2008-07-24
JP2010516686A (en) 2010-05-20
MX2009007313A (en) 2009-07-15
KR20090105944A (en) 2009-10-07
WO2008088935A2 (en) 2008-07-24
TW200835503A (en) 2008-09-01
AR064947A1 (en) 2009-05-06
CN101616926A (en) 2009-12-30

Similar Documents

Publication Publication Date Title
UY32490A (en) BETA-SECRETASA INHIBITORS
CO6620055A2 (en) Certain amino-pyrimidines, compositions thereof and methods for the use thereof
PA8799101A1 (en) TIENOPIRIMIDINE AND PIRAZOLOPIRIMIDINE COMPOUNDS AND THEIR USE AS INHIBITORS OF MTIN QUINASE AND KINASE P13
NI201200132A (en) ARYLMETOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS THAT INCLUDE THEM AND METHODS FOR USING THEM
NI200900170A (en) SUBSTITUTE ISOINDOLINE 4 '- O - DERIVATIVES AND COMPOSITIONS THAT INCLUDE THEM AND METHODS FOR USING THEM.
CR11819A (en) 5-SUBSTITUTED ISOINDOLINE COMPOUNDS
ECSP109856A (en) DERIVATIVES OF OXADIAZOL AND ITS USE AS POTENTIALS OF METABOTROPIC RECEIVERS OF GLUTAMATE - 842
CR20170159A (en) NEW TRICYCLIC COMPOUNDS
DK2315756T3 (en) 1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLAMIN-2,3-DIOXYGENASE
CU20110235A7 (en) IMIDAZOLIDIN-2-ONA 1,3-DISPOSED DERIVATIVES AS CYP17 INHIBITORS
DK2225206T3 (en) AMINOBENZAMIDE DERIVATIVES AS APPLICABLE AGENTS FOR COMBATING ANIMALS
ATE519764T1 (en) SPIROINDOLINONE DERIVATIVES
DK1981875T3 (en) SUBSTITUTED INDOLYLALKYLAMINODE DERIVATIVES AS INHIBITORS OF HISTONDEACETYLASE
AR062211A1 (en) DERIVATIVES OF 6-CARBOXI-NORMORFINANO. PHARMACEUTICAL COMPOSITIONS
DK2160389T3 (en) Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
DK2081895T3 (en) HYDROBENZAMIDE DERIVATIVES AS INHIBITORS OF HSP90
DK2155731T3 (en) 1,3-Dihydroimidazole-2-thione derivatives as inhibitors of dopamine beta-hydroxylase
DK2160380T3 (en) Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
UY32153A (en) PY13KA (ALFA) AND MTOR PYRIDOMIDINONE INHIBITORS
CR20140314A (en) FORMULATIONS OF (+) - 2- [1- (3-ETOXI-4-METOXI-PHENYL) -2-METALSUNFONIL- ETIL] -4-AMINOISOINDOLIN-1,3-DIONA OIL
AR088297A1 (en) R (+) - N-FORMIL-PROPARGIL-AMINOINDANO
DK2049480T3 (en) 2-arylindole derivatives as mPGES-1 inhibitors
ECSP10010167A (en) NEW OPHTHALMIC COMPOSITIONS
CR20110680A (en) HETEROCICLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
CL2012000278A1 (en) Process for obtaining derivatives of 5-trifluoromethyl-pyrimidines; and one of the intermediate compounds considered.